A Study to Evaluate the Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% BID Compared to Vehicle in the Treatment of Bacterial Conjunctivitis

Trial Profile

A Study to Evaluate the Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% BID Compared to Vehicle in the Treatment of Bacterial Conjunctivitis

Discontinued
Phase of Trial: Phase III

Latest Information Update: 04 Nov 2014

At a glance

  • Drugs Besifloxacin (Primary)
  • Indications Bacterial infections; Infectious conjunctivitis
  • Focus Therapeutic Use
  • Sponsors Bausch & Lomb
  • Most Recent Events

    • 01 Sep 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 01 Mar 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 09 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top